Page 2 - Timothya Springer News Today

Cartesian Therapeutics, Inc. (NASDAQ:RNAC – Get Free Report)’s share price reached a new 52-week low on Friday . The stock traded as low as $13.19 and last traded at $14.69, with a volume of 14103 shares changing hands. The stock had previously closed at $15.12. Wall Street Analysts Forecast Growth Separately, HC Wainwright restated a […]

/PRNewswire/ -- Sollis Health, the first concierge provider to offer its members ER-level diagnostics and care, and Prenuvo, the company pioneering proactive...

Combined company to be Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing Tectonic’s novel GPCR-targeted therapeutic proteins $130.7 million in private financing...

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

13.11.2023 - – Merger creates a fully integrated, publicly traded company pioneering RNA cell therapy for the treatment of autoimmune disease – – Cartesian’s wholly owned pipeline includes a Phase 2 lead asset, Descartes-08, for which deep and durable responses ... Seite 1

Prenuvo, the company pioneering proactive whole-body MRI imaging for the early detection of cancer and diseases, presented three AI-assisted research abstracts highlighting the significant correlation between lifestyle factors and brain volume changes. The studies, conducted on over 10,000 consenting anonymized Prenuvo patients, shed light on the crucial role of visceral abdominal fat in predicting midlife brain atrophy, underscoring the importance of managing visceral fat for long term...

Nuvalent (NASDAQ:NUVL – Get Rating) and Morphic (NASDAQ:MORF – Get Rating) are both mid-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, risk, valuation, profitability and institutional ownership. Insider & Institutional Ownership 79.8% of Morphic shares are held by […]

CohBar (NASDAQ:CWBR – Get Rating) and Morphic (NASDAQ:MORF – Get Rating) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, analyst recommendations, profitability, risk and earnings. Insider and Institutional Ownership 7.2% of CohBar shares are held by institutional […]

Morphic Holding, Inc. (NASDAQ:MORF – Get Rating) Director Timothy A. Springer bought 1,050,000 shares of the firm’s stock in a transaction on Wednesday, May 3rd. The shares were purchased at an average price of $45.00 per share, for a total transaction of $47,250,000.00. Following the purchase, the director now owns 2,768,464 shares in the company, […]

Aura Biosciences (NASDAQ:AURA – Get Rating) and Scholar Rock (NASDAQ:SRRK – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings and valuation. Profitability This table compares Aura Biosciences and Scholar Rock’s […]